Dendrimers in Corneal Drug Delivery: Recent Developments and Translational Opportunities

Abstract

Dendrimers are biocompatible organic nanomaterials with unique physicochemical properties, making them the focus of recent research in drug delivery. The cornea of the human eye presents a challenge for drug transit due to its inherently impenetrable nature, requiring nanocarrier-mediated targeted drug delivery. This review intends to examine recent advancements in the use of dendrimers for corneal drug delivery, including their properties and their potential for treating various ocular diseases. The review will also highlight the benefit of the novel technologies that have been developed and applied in the field, such as corneal targeting, drug release kinetics, treatments for dry eye disease, antibacterial drug delivery, corneal inflammation, and corneal tissue engineering. The review seeks to provide a comprehensive overview of the current state of research in this field, along with the translational developments in the field of dendrimer-based therapeutics and imaging agents and inspire the potential for future developments and translational opportunities in dendrimers based corneal drug delivery.

Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases

“…IL-13 is expressed in neurons and can modulate neuronal activity and synaptic plasticity 73 . Studies have shown that IL-13 protects neurons against excitotoxic insults after TBI 22 . There were significant differences in the IL-13 expression based on treatment [F (3, 30) =15.41, p < 0.0001].…”

“…Within the realm of polymer-based nanoparticulate drug delivery systems, dendrimers, which are hyper-branched, uniformly sized, monodispersed synthetic macromolecules with precisely defined structure and composition, have gained extensive utilization in the field of drug delivery systems 21 , 22 . This arises from the meticulous control over their properties like molecular structure, size, shape and solubility.…”

Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease

“…Dendrimers are nanoscale macromolecules characterized by a tree-like or dendritic structure, featuring highly branched repeating units radiating from a central core. The three-dimensional shape and size of the dendrimer are determined by the number and arrangement of arms comprising its core, while its physiochemical proprieties are dictated by the surface groups [ 99 ].…”

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer

“…It can also significantly prolong the half-life of the drug in the body and minimize the frequency of drug administration. In addition, the surface of dendrimers is densely covered with various functional groups, which can specifically bind to target cells after modification, realizing the targeted delivery of DOX and enhancing the chemotherapeutic effect of TNBC ( Mukherjee et al, 2022 ; Dhull et al, 2023 ). Thus, based on these properties of dendrimers, they have led to the development of novel drug delivery technologies.…”